HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chao-Liang Wu Selected Research

3-hydroxyphenyltrimethylammonium

4/2019Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer.
11/2013Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
10/2009Prognostic relevance of prothymosin-alpha expression in human upper urinary tract transitional cell carcinoma.
1/2009Aberrant prothymosin-alpha expression in human bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chao-Liang Wu Research Topics

Disease

41Neoplasms (Cancer)
11/2022 - 01/2003
13Inflammation (Inflammations)
03/2022 - 04/2005
11Urinary Bladder Neoplasms (Bladder Cancer)
04/2019 - 02/2006
10Experimental Arthritis
11/2022 - 01/2005
10Arthritis (Polyarthritis)
01/2020 - 04/2005
8Rheumatoid Arthritis
02/2016 - 01/2005
7Hepatocellular Carcinoma (Hepatoma)
07/2017 - 01/2003
5Lung Neoplasms (Lung Cancer)
05/2022 - 05/2010
5Disease Progression
11/2019 - 01/2005
5Infections
01/2017 - 10/2006
4Neoplasm Metastasis (Metastasis)
01/2020 - 08/2008
4Non-alcoholic Fatty Liver Disease
01/2020 - 11/2013
4Osteoarthritis
10/2012 - 02/2009
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 08/2012
3Ischemia
03/2022 - 07/2010
3Carcinogenesis
06/2019 - 07/2016
3Human Influenza (Influenza)
01/2017 - 10/2011
3Insulin Resistance
07/2016 - 11/2015
3Hypoxia (Hypoxemia)
04/2014 - 02/2005
3Transitional Cell Carcinoma
10/2009 - 02/2006
2Neuralgia (Stump Neuralgia)
03/2022 - 11/2002
2Idiopathic Pulmonary Fibrosis
06/2021 - 05/2021
2Hypertension (High Blood Pressure)
01/2021 - 03/2014
2Gestational Diabetes (Gestational Diabetes Mellitus)
01/2020 - 01/2020
2Tendinopathy (Tendonitis)
12/2019 - 01/2018
2Hyperplasia
10/2016 - 02/2007
2Synovitis
10/2016 - 01/2005
2Chronic Obstructive Pulmonary Disease (COPD)
02/2016 - 01/2013
2Emphysema
02/2016 - 01/2013
2Carcinoma (Carcinomatosis)
11/2013 - 12/2005
2Colonic Neoplasms (Colon Cancer)
05/2012 - 09/2010
2Necrosis
06/2011 - 10/2006
2Cataract (Cataracts)
09/2006 - 06/2006
1Diabetic Neuropathies (Diabetic Neuropathy)
03/2022
1Myocardial Ischemia (Ischemic Heart Diseases)
03/2022
1Hemorrhage
06/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2021
1Anemia
06/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
06/2021

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
05/2022 - 11/2002
9CytokinesIBA
06/2021 - 01/2005
7prothymosin alphaIBA
01/2017 - 05/2005
6Cisplatin (Platino)FDA LinkGeneric
10/2021 - 05/2005
6Therapeutic UsesIBA
07/2017 - 01/2005
5kallistatinIBA
09/2015 - 04/2005
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 12/2004
4Biomarkers (Surrogate Marker)IBA
08/2019 - 09/2010
43-hydroxyphenyltrimethylammoniumIBA
04/2019 - 01/2009
4Antineoplastic Agents (Antineoplastics)IBA
05/2009 - 12/2004
3MicroRNAs (MicroRNA)IBA
11/2022 - 10/2012
3Peptides (Polypeptides)IBA
03/2022 - 01/2017
3Small Interfering RNA (siRNA)IBA
06/2021 - 02/2008
3Fibrinogen (Factor I)FDA Link
01/2021 - 01/2016
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 06/2019
3Interleukin-17 (Interleukin 17)IBA
10/2016 - 02/2011
3Thrombospondin 1IBA
10/2010 - 01/2005
2Complementary DNA (cDNA)IBA
03/2022 - 10/2020
2LuciferasesIBA
03/2022 - 01/2007
2Long Noncoding RNAIBA
06/2021 - 12/2020
2Messenger RNA (mRNA)IBA
06/2021 - 01/2011
2nintedanibIBA
06/2021 - 05/2021
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 01/2010
2fullerenolIBA
01/2020 - 06/2019
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2020 - 05/2017
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2019 - 05/2012
2Nuclear Localization Signals (Nuclear Localization Signal)IBA
04/2019 - 04/2007
2TensinsIBA
04/2019 - 05/2012
2Indicators and Reagents (Reagents)IBA
04/2019 - 11/2013
2Estrogen ReceptorsIBA
01/2018 - 07/2016
2Pharmaceutical PreparationsIBA
05/2017 - 08/2012
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 12/2015
2Histone Deacetylases (Histone Deacetylase)IBA
02/2016 - 01/2013
2Histones (Histone)IBA
02/2016 - 01/2013
2SmokeIBA
02/2016 - 01/2013
2Insulin (Novolin)FDA Link
01/2016 - 11/2015
2Etoposide (VP 16)FDA LinkGeneric
11/2015 - 10/2006
2Toll-Like Receptor 4IBA
11/2015 - 01/2010
2LipidsIBA
10/2014 - 11/2013
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
06/2014 - 03/2011
2Immunosuppressive Agents (Immunosuppressants)IBA
06/2013 - 03/2011
2Transforming Growth Factor beta (TGF-beta)IBA
06/2013 - 01/2005
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2013 - 08/2008
2NF-kappa B (NF-kB)IBA
01/2013 - 01/2010
2Biological ProductsIBA
08/2012 - 08/2008
2ErbB Receptors (EGF Receptor)IBA
09/2010 - 12/2005
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2009 - 10/2006
2GoldIBA
07/2008 - 09/2007
2Cytosine DeaminaseIBA
01/2007 - 10/2006
2Flucytosine (Ancobon)FDA Link
01/2007 - 10/2006
1crassolideIBA
05/2022
14-phenylbutyric acid (Buphenyl)FDA Link
05/2022
1mirogabalinIBA
03/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2022
1Imiquimod (Aldara)FDA LinkGeneric
06/2021

Therapy/Procedure

14Therapeutics
05/2022 - 01/2003
3Drug Therapy (Chemotherapy)
05/2017 - 08/2012
2Intra-Articular Injections
01/2020 - 06/2019
2Traditional Medicine (Folk Remedies)
09/2014 - 03/2014
2Nephroureterectomy
10/2009 - 12/2005
2Aftercare (After-Treatment)
01/2007 - 02/2006